Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mutant α2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome
Alicia A. Nugent, Jong G. Park, Yan Wei, Alan P. Tenney, Nicole M. Gilette, Michelle M. DeLisle, Wai-Man Chan, Long Cheng, Elizabeth C. Engle
Alicia A. Nugent, Jong G. Park, Yan Wei, Alan P. Tenney, Nicole M. Gilette, Michelle M. DeLisle, Wai-Man Chan, Long Cheng, Elizabeth C. Engle
View: Text | PDF
Research Article Neuroscience Ophthalmology

Mutant α2-chimaerin signals via bidirectional ephrin pathways in Duane retraction syndrome

  • Text
  • PDF
Abstract

Duane retraction syndrome (DRS) is the most common form of congenital paralytic strabismus in humans and can result from α2-chimaerin (CHN1) missense mutations. We report a knockin α2-chimaerin mouse (Chn1KI/KI) that models DRS. Whole embryo imaging of Chn1KI/KI mice revealed stalled abducens nerve growth and selective trochlear and first cervical spinal nerve guidance abnormalities. Stalled abducens nerve bundles did not reach the orbit, resulting in secondary aberrant misinnervation of the lateral rectus muscle by the oculomotor nerve. By contrast, Chn1KO/KO mice did not have DRS, and embryos displayed abducens nerve wandering distinct from the Chn1KI/KI phenotype. Murine embryos lacking EPH receptor A4 (Epha4KO/KO), which is upstream of α2-chimaerin in corticospinal neurons, exhibited similar abducens wandering that paralleled previously reported gait alterations in Chn1KO/KO and Epha4KO/KO adult mice. Findings from Chn1KI/KI Epha4KO/KO mice demonstrated that mutant α2-chimaerin and EphA4 have different genetic interactions in distinct motor neuron pools: abducens neurons use bidirectional ephrin signaling via mutant α2-chimaerin to direct growth, while cervical spinal neurons use only ephrin forward signaling, and trochlear neurons do not use ephrin signaling. These findings reveal a role for ephrin bidirectional signaling upstream of mutant α2-chimaerin in DRS, which may contribute to the selective vulnerability of abducens motor neurons in this disorder.

Authors

Alicia A. Nugent, Jong G. Park, Yan Wei, Alan P. Tenney, Nicole M. Gilette, Michelle M. DeLisle, Wai-Man Chan, Long Cheng, Elizabeth C. Engle

×

Figure 1

Chn1KI mutations are gain-of-function and alter abducens development.

Options: View larger image (or click on image) Download as PowerPoint

Chn1KI mutations are gain-of-function and alter abducens development.
(...
(A–C) Eyes of Chn1WT/WT (A), Chn1KI/KI (B), and Chn1KO/KO (C) adult mice (Chn1WT/WT: n = 0/44 affected; Chn1WT/KI: 61.3% affected, n = 144/186; Chn1KI/KI: 71.8% affected, n = 28/39; Chn1KO/KO: n = 0/9 affected). (D–F) Whole mount neurofilament staining of E11.5 Chn1WT/WT (D), Chn1KI/KI (E), and Chn1KO/KO (F) embryos. Scale bars: 500 μm. White box, enlargement in G–I. Scale bars: 500 μm. (G–I) Developing abducens nerve (VI) in E11.5 Chn1WT/WT (G), Chn1KI/KI (H), and Chn1KO/KO (I) embryos. Arrow, stalling region in H or aberrant fasciculation with facial nerve (VII) in I; arrowhead, dorsally projecting nerve bundles. Area 1, abducens hindbrain exit region; area 2, abducens fasciculation region; area 3, abducens EOM innervation region. III, oculomotor, VI, abducens, VII, facial nerves; O, orbit. Scale bars: 100 μm. (J–L) Number of abducens nerve bundles immediately after exit from the hindbrain within area 1 (J); abducens length measured from hindbrain exit to nerve terminus at the orbit (K); and abducens diameter measured at line denoting area 3 (L). Chn1WT/WT: n = 20/20 nerves reach orbit (n = 10 embryos); Chn1KI/KI: 3/10 nerves reach orbit (n = 5 embryos); Chn1KO/KO: 10/10 reach orbit, 7/10 nerves fasciculate with the facial nerve (n = 5 embryos). Data represent mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001, 1-way ANOVA with Tukey’s test. Red, neurofilament; green, Hb9-GFP (26).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts